Clinical trial
Tamoxifen in Treatment of Acute Mania
NCT00411203 · Stanley Medical Research Institute, Other · Completed
Key facts
| NCT number | NCT00411203 |
|---|---|
| Title | Tamoxifen in Treatment of Acute Mania |
| Official title | Double Blind Placebo Controlled Trial of a Protein Kinase C Inhibitor: Tamoxifen Citrate in Treatment of Acute Mania |
| Lead sponsor | Stanley Medical Research Institute, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Tamoxifen Citrate, Placebo |
| Enrollment | 66 |
| Start date | Apr 1, 2003 |
| Completion | Jun 1, 2006 |
| First posted | Dec 13, 2006 |
| Last update posted | Jul 31, 2014 |
| Countries | Turkey (Türkiye) |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: